CRP and COVID-19: Our study clearly demonstrates that the values of PCT and CRP to detect secondary infections in COVID-19, which we previously showed to be helpful in patients who did not receive immunomodulatory treatment [5], is considerably reduced by use of dexamethasone, whether or not in combination with tocilizumab.